methylprednisolone and loxoribine

methylprednisolone has been researched along with loxoribine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Markovic-Plese, S; Tao, Y; Zhang, X	1

Other Studies

1 other study(ies) available for methylprednisolone and loxoribine

Article	Year
Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS). Journal of neuroimmunology, 2016, 09-15, Volume: 298 Topics: B-Lymphocytes; Case-Control Studies; CD4 Antigens; Cytokines; Drug Synergism; Female; Glatiramer Acetate; Guanosine; Humans; Immunologic Factors; Interferon Regulatory Factor-7; Interferon-beta; Male; Methylprednisolone; Multiple Sclerosis, Relapsing-Remitting; Myeloid Differentiation Factor 88; STAT1 Transcription Factor; Tetraspanin 29; Toll-Like Receptor 7; Toll-Like Receptor 9	2016

Article

Year

Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS).

Journal of neuroimmunology, 2016, 09-15, Volume: 298

Topics: B-Lymphocytes; Case-Control Studies; CD4 Antigens; Cytokines; Drug Synergism; Female; Glatiramer Acetate; Guanosine; Humans; Immunologic Factors; Interferon Regulatory Factor-7; Interferon-beta; Male; Methylprednisolone; Multiple Sclerosis, Relapsing-Remitting; Myeloid Differentiation Factor 88; STAT1 Transcription Factor; Tetraspanin 29; Toll-Like Receptor 7; Toll-Like Receptor 9

2016